NCT02740634 - Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Atypical Alzheimer's DiseaseLogopenic Progressive Aphasia (LPA)Posterior Cortical Atrophy (PCA)Alzheimer DiseaseAlzheimer Disease, Early OnsetAmnestic DisorderAmnestic SymptomsAmnestic Mild Cognitive Disorder

Interventions

DRUG

F-18 AV 1451

Tau binding agent

DRUG

C-11 PiB

Amyloid binding agent

Trial Locations (1)

55905

RECRUITING

Mayo Clinic, Rochester